Preadmission Bisphosphonate and Mortality in Critically Ill Patients

  1. Inicio
  2. »
  3. Sin categoría
  4. »
  5. Preadmission Bisphosphonate and Mortality in Critically Ill Patients

J Clin Endocrinol Metab. 2016 May;101(5):1945-53. doi: 10.1210/jc.2015-3467. Epub 2016 Jan 18.

Preadmission bisphosphonate use was associated with superior survival among critically ill patients. Prospective studies examining the effects of bisphosphonate in critical illness are required.

Autor: Lee P, Ng C, Slattery A, Nair P, Eisman JA, Center JR.
Patrocinadores de la web
Lilly
Laboratorios Rubió
Grupo Italfármaco
UCB-Pharma
Theramex
Stada
Gedeon Richter
Kyowa Kirin
Amgen
Gebro
Faes Farma
Meiji Pharma
Meiji Pharma